Italia markets closed

ILMN Jan 2025 200.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
2,10000,0000 (0,00%)
In data: 02:41PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,1000
Aperto2,1000
Denaro1,8000
Lettera2,1000
Prezzo d'esercizio200,00
Scadenza2025-01-17
Min-Max giorno2,1000 - 2,1000
Contratto - Min-MaxN/D
Volume2
Open Interest566
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera